Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.84 USD | -4.71% | -4.24% | -84.55% |
May. 14 | Wolfe Research Downgrades RAPT Therapeutics to Peer Perform From Outperform | MT |
May. 10 | Guggenheim Downgrades RAPT Therapeutics to Neutral From Buy | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 141M |
---|---|---|---|---|---|
Net income 2024 * | -112M | Net income 2025 * | -132M | EV / Sales 2024 * | - |
Net cash position 2024 * | 152M | Net cash position 2025 * | 216M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.45
x | P/E ratio 2025 * |
-1.53
x | Employees | 126 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.64% |
Latest transcript on RAPT Therapeutics, Inc.
1 day | -4.71% | ||
1 week | -4.24% | ||
Current month | -4.24% | ||
1 month | -52.48% | ||
3 months | -58.62% | ||
6 months | -78.06% | ||
Current year | -84.55% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Wong
CEO | Chief Executive Officer | 52 | 15-07-31 |
Rodney Young
DFI | Director of Finance/CFO | 61 | 19-12-01 |
Jim Farmer
CTO | Chief Tech/Sci/R&D Officer | - | 22-05-03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mary Gray
BRD | Director/Board Member | 71 | 19-12-03 |
William Rieflin
CHM | Chairman | 64 | 15-04-30 |
Wendye Robbins
BRD | Director/Board Member | 63 | 19-10-21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.05% | 0 M€ | 0.00% | - | |
0.02% | 1,557 M€ | +8.20% | - | |
0.02% | 248 M€ | +11.05% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 3.84 | -4.71% | 365,096 |
24-06-06 | 4.03 | -3.36% | 279,661 |
24-06-05 | 4.17 | +5.84% | 665,841 |
24-06-04 | 3.94 | -1.01% | 486,918 |
24-06-03 | 3.98 | -0.75% | 889,908 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-84.55% | 141M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.31% | 16.5B | |
+2.44% | 13.39B | |
+27.89% | 11.1B |
- Stock Market
- Equities
- RAPT Stock